Casdin Capital, LLC Q4 2023 Filing
Filed February 14, 2024
Portfolio Value
$1.0T
Holdings
36
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (36 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 5,714,775 | $163.9B | 16.09% | |
| 2 | BLFSBIOLIFE SOLUTIONS INC | 8,707,165 | $141.5B | 13.89% | |
| 3 | SRPTSAREPTA THERAPEUTICS INC | 1,006,500 | $97.1B | 9.53% | |
| 4 | RLAYRELAY THERAPEUTICS INC | 7,387,943 | $81.3B | 7.98% | |
| 5 | ILMNILLUMINA INC | 338,000 | $47.1B | 4.62% | Call |
| 6 | GPCRSTRUCTURE THERAPEUTICS INC | 1,116,867 | $45.5B | 4.47% | Call |
| 7 | NTLAINTELLIA THERAPEUTICS INC | 1,450,000 | $44.2B | 4.34% | |
| 8 | VERVVERVE THERAPEUTICS INC | 3,009,094 | $41.9B | 4.12% | |
| 9 | ALNYALNYLAM PHARMACEUTICALS INC | 195,000 | $37.3B | 3.66% | |
| 10 | SLGCUSDSOMALOGIC INC | 12,604,275 | $31.9B | 3.13% | |
| 11 | EXASEXACT SCIENCES CORP | 420,000 | $31.1B | 3.05% | |
| 12 | 2L9BLUEPRINT MEDICINES CORP | 326,378 | $30.1B | 2.96% | |
| 13 | PLRXPLIANT THERAPEUTICS INC | 1,577,108 | $28.6B | 2.80% | |
| 14 | DNLIDENALI THERAPEUTICS INC | 1,300,000 | $27.9B | 2.74% | |
| 15 | FDMT4D MOLECULAR THERAPEUTICS IN | 1,033,811 | $20.9B | 2.06% | |
| 16 | TNYATENAYA THERAPEUTICS INC | 6,381,377 | $20.7B | 2.03% | |
| 17 | BEAMBEAM THERAPEUTICS INC | 528,000 | $14.4B | 1.41% | |
| 18 | ABCLABCELLERA BIOLOGICS INC | 2,360,129 | $13.5B | 1.32% | |
| 19 | TNGXTANGO THERAPEUTICS INC | 1,188,349 | $11.8B | 1.15% | |
| 20 | IPSCCENTURY THERAPEUTICS INC | 3,206,380 | $10.6B | 1.04% | |
| 21 | RNAAVIDITY BIOSCIENCES INC | 1,175,750 | $10.6B | 1.04% | |
| 22 | NGNENEUROGENE INC | 524,616 | $10.2B | 1.00% | |
| 23 | PACBPACIFIC BIOSCIENCES CALIF IN | 1,035,859 | $10.2B | 1.00% | |
| 24 | WGSGENEDX HOLDINGS CORP | 3,095,511 | $8.5B | 0.84% | |
| 25 | FATEFATE THERAPEUTICS INC | 2,050,000 | $7.7B | 0.75% | |
| 26 | CDXSCODEXIS INC | 2,000,000 | $6.1B | 0.60% | |
| 27 | TSVT*2SEVENTY BIO INC | 1,182,623 | $5.0B | 0.50% | |
| 28 | ABSIABSCI CORPORATION | 973,260 | $4.1B | 0.40% | |
| 29 | PRMEPRIME MEDICINE INC | 367,175 | $3.3B | 0.32% | |
| 30 | SNDXSYNDAX PHARMACEUTICALS INC | 150,000 | $3.2B | 0.32% | |
| 31 | GLUEMONTE ROSA THERAPEUTICS INC | 510,882 | $2.9B | 0.28% | |
| 32 | FLBSTANDARD BIOTOOLS INC | 1,200,000 | $2.7B | 0.26% | |
| 33 | EXAIEUREXSCIENTIA PLC | 213,900 | $1.4B | 0.13% | |
| 34 | LIANYLIANBIO | 206,415 | $922.7M | 0.09% | |
| 35 | —SINGULAR GENOMICS SYSTEMS IN | 1,323,885 | $609.1M | 0.06% | |
| 36 | KRON1USDKRONOS BIO INC | 123,839 | $154.8M | 0.02% |